Comprehensive analysis of PD‐L1 in non‐small cell lung cancer with emphasis on survival benefit, impact of driver mutation and histological types, and archival tissue-Reference-Cited by-同舟云学术

Comprehensive analysis of PD‐L1 in non‐small cell lung cancer with emphasis on survival benefit, impact of driver mutation and histological types, and archival tissue

Published:2021-11-28 Issue:1 Volume:13 Page:38-47
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Wang Chin‐Chou¹²³^ORCID,Huang Kuo‐Tung¹,Chang Huang‐Chih¹^ORCID,Tseng Chia‐Cheng¹,Lai Chien‐Hao¹,Lan Jui⁴,Liu Ting‐Ting⁴,Huang Chao‐Cheng⁴⁵^ORCID,Lin Meng‐Chih¹²

Affiliation:

1. Divisions of Pulmonary & Critical Care Medicine, Department of Internal Medicine Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine Kaohsiung Taiwan

2. Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital Chang Gung University College of Medicine Kaohsiung Taiwan

3. Department of Respiratory Care Chang Gung University of Science and Technology Chiayi Taiwan

4. Department of Pathology, Chang Gung Memorial Hospital‐Kaohsiung Medical Center Chang Gung University College of Medicine Kaohsiung Taiwan

5. Biobank and Tissue Bank and Department of Pathology Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine Kaohsiung Taiwan

Funder

Chang Gung Medical Foundation

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14216

Reference31 articles.

1. Cancer Immunotherapy

2. The blockade of immune checkpoints in cancer immunotherapy

3. Oncology Meets Immunology: The Cancer-Immunity Cycle